Atara's Pascal Touchon on allo
- blonca9
- Jan 18, 2023
- 1 min read
Updated: Jun 16, 2023
Atara Biotherapeutics' CEO Pascal Touchon discusses his company's approved allogeneic cell therapy, and the EBV theory of multiple sclerosis.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.